Trial · NCT00201643
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Composite Neonatal Morbidity < 34 Weeks Gestation at Time of Birth. | Rescue Course of Betamethasone or Dexamethasone | 71 | participants | ||
| Composite Neonatal Morbidity < 34 Weeks Gestation at Time of Birth. | Placebo (Normal Saline) | 105 | participants | ||
| Gestational Age at (@) Delivery | Rescue Course of Betamethasone or Dexamethasone | 33.1 | Standard Deviation 3.1 | Weeks | |
| Gestational Age at (@) Delivery | Placebo (Normal Saline) | 33.0 | Standard Deviation 3.1 | Weeks | |
| Neonatal Birth Weight Reported in Grams | Rescue Course of Betamethasone or Dexamethasone | 1905 | Standard Deviation 738 | grams | |
| Neonatal Birth Weight Reported in Grams | Placebo (Normal Saline) | 1920 | Standard Deviation 667 | grams | |
| Interuterine Growth Restriction (IUGR) or Small for Gestational Age(SGA)in Babies Delivering at < 34 Weeks Gestation. | Rescue Course of Betamethasone or Dexamethasone | 25 | paticipants | ||
| Interuterine Growth Restriction (IUGR) or Small for Gestational Age(SGA)in Babies Delivering at < 34 Weeks Gestation. | Placebo (Normal Saline) | 20 | paticipants | ||
| Neonatal Head Circumference Taken at Time of Birth. | Rescue Course of Betamethasone or Dexamethasone | 30.2 | Standard Deviation 3.0 | centemeters (cm) | |
| Neonatal Head Circumference Taken at Time of Birth. | Placebo (Normal Saline) | 30.0 | Standard Deviation 2.9 | centemeters (cm) | |
| Number of Babies Who Required Ventilatory Support Within the First 28 Days of Life. | Rescue Course of Betamethasone or Dexamethasone | 70 | participants | ||
| Number of Babies Who Required Ventilatory Support Within the First 28 Days of Life. | Placebo (Normal Saline) | 95 | participants | ||
| Number of Neonates Who Required Surfactant Therapy After Birth. | Rescue Course of Betamethasone or Dexamethasone | 70 | participant | ||
| Number of Neonates Who Required Surfactant Therapy After Birth. | Placebo (Normal Saline) | 99 | participant | ||
| Number of Neonates With Pneumothorax | Rescue Course of Betamethasone or Dexamethasone | 4 | participants | ||
| Number of Neonates With Pneumothorax | Placebo (Normal Saline) | 4 | participants | ||
| Maternal Infectious Morbidity. | Rescue Course of Betamethasone or Dexamethasone | 8 | participants | ||
| Maternal Infectious Morbidity. | Placebo (Normal Saline) | 10 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00201643/results